Clinical and Radiological Evaluation of Patients With DDD Following TLIF With 3-D Printed Titanium Cage

Intervertebral Disc Disease Clinical Trial

Official title:
Fusion Rate and Clinical Outcomes Following 1 or 2 Level Open Transforaminal Lumbar Interbody Fusion for Degenerative Disc Disease With Novel 3-D Printed Titanium Cages With Pedicle Screw Fixation

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the fusion rate and clinical outcomes at 1 year of 20 patients with degenerative disc disease who undergo a Transforaminal Lumbar Interbody Fusion (TLIF) with the Stryker Tritanium Spinal System. This is an on-label, post-market outcomes study to build on the body of long-term evidence for the device.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03018392
Study type	Interventional
Source	Bone and Joint Clinic of Baton Rouge
Contact
Status	Completed
Phase	N/A
Start date	January 2017
Completion date	January 28, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01941563` - A Study of SI-6603 in Patients With Lumbar Disc Herniation	Phase 3
Completed	`NCT02931279` - PASS OCT® Post-market Clinical Follow-up
Completed	`NCT02225444` - A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP®
Completed	`NCT02421601` - A Study of SI-6603 in Patients With Lumbar Disc Herniation	Phase 3
Terminated	`NCT02381067` - A Prospective Study of NuCel® in Cervical Spine Fusion	N/A
Completed	`NCT01860417` - Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV)	Phase 1/Phase 2
Completed	`NCT01513694` - Clinical Trial Based on the Use of Mesenchymal Stem Cells From Autologous Bone Marrow in Patients With Lumbar Intervertebral Degenerative Disc Disease	Phase 1/Phase 2
Completed	`NCT02023372` - Efficacy Study of NuCel® in Patients Undergoing Fusion of the Lumbar Spine	N/A